Christopher Ennis
Gerontology · Macon, GANPI 1740739853
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,372 and has fallen 81.5% since, to $254 in 2025.
Across 134 payments — averaging $24.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$682
- Novartis$295
- Actelion Pharmaceuticals US, Inc.$285
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$236
- Novo Nordisk$195
- Abbott$191
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,251100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 9 | $682 |
| Novartis | 17 | $295 |
| Actelion Pharmaceuticals US, Inc. | 14 | $285 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $236 |
| Novo Nordisk | 10 | $195 |
| Abbott | 5 | $191 |
| Amgen | 3 | $156 |
| Pfizer | 8 | $147 |
| Merck | 8 | $147 |
| Alnylam Pharmaceuticals Inc. | 6 | $136 |
| AstraZeneca | 8 | $122 |
| Daiichi Sankyo Inc. | 6 | $120 |
| Impulse Dynamics (USA) Inc. | 4 | $107 |
| Boehringer Ingelheim | 5 | $95 |
| E.r. Squibb & Sons, L.L.C. | 5 | $82 |
| Bayer | 3 | $49 |
| United Therapeutics Corporation | 2 | $44 |
| Boston Scientific | 2 | $37 |
| Chiesi USA, Inc. | 2 | $32 |
| Cvrx, Inc. | 1 | $26 |
| Haemonetics Corporation | 1 | $25 |
| Johnson & Johnson | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Kestra Medical Technology Services, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$118
- Impella$106
- CARDIOMEMS$101
How this compares
$3,251 in reported general payments places this provider in the 80th percentile of 197 gerontology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gerontology in Macon
- Michelle DudleyMacon$10K
- Stephen JenkinsMacon$3K
- Carolyn ClevengerAtlanta$65K
- Mitzi LewisAtlanta$37K
- Constance MeinkenAtlanta$36K
- Britni JohnsonSavannah$24K
- Doreen AbrigoWarner Robins$14K
- Taylor SwineaWaycross$10K
- Kathleen BradfordAtlanta$8K
- Teresa VickersWarner Robins$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.